Nymox Pharmaceutical Corp. (NYMX) Key Ratios

Profile for Nymox Pharmaceutical Corp. (NYMX)

Income Statements

Revenue (LTM) ($):	2.65 m
Revenue per Share (LTM) ($):	0.08
Revenue per Employee (LTM) ($):	120,425.09
Revenue Growth 3 Yr:	61.20%
Revenue Growth 5 Yr:	27.44%

Dividends & Splits

Annual Dividend Rate ($):	N/A
Annual Dividend Yield:	N/A
Dividend Growth 3 Yr:	N/A
Dividend Growth 5 Yr:	N/A
Ex-Dividend Date:	N/A
Payment Type:	N/A

Financial Strength (LTM)

Quick Ratio:	2.00
Current Ratio:	2.00
Long Term Debt to Total Capital:	N/A
Total Debt to Equity:	N/A
Interest Coverage:	N/A
Leverage Ratio:	N/A

Profitability (LTM)

Gross Margin:	88.60%
EBIT Margin:	N/A
EBITDA Margin:	N/A
Pre-Tax Profit Margin:	N/A
Profit Margin (Cont. Op):	N/A
Profit Margin (Total Op):	N/A

Management Effectiveness

LTM

5 Yr Avg

Return on Equity	N/A	N/A
Return on Capital	-2,844.80%	-2,844.80%
Return on Assets	-99.90%	-99.90%

Assets

Asset Turnover:	0.70
Inventory Turnover:	217.00
Receivable Turnover:	6.00

Valuation Measures

P/E Ratio:	N/A
P/E High - Last 5 Years:	N/A
P/E Avg. High - Last 5 Years:	N/A
P/E Low - Last 5 Years:	N/A
P/E Avg. Low - Last 5 Years:	N/A

Price to Sales:	106.32
Price to Book:	N/A
Price to Tangible Book:	-47.74
Price to Cash Flow:	-27.70
Price to Free Cash:	81.20

Financial Market Data powered by QuoteMedia.com. All rights reserved. View the Terms of Use
NYSE/AMEX data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless indicated.
RT Realtime, EOD End Of Day, PD Previous Day. PW Previous Week.

All information displayed and available herein is on an "as is", "as available" basis and neither InvestorPoint.com nor any of its underlying service providers, information providers, licensors, employees, distributors or agents make any representations as to the suitability of our service or the materials for any purpose. The information is not intended for trading purposes or advice. We specifically disclaim any representations or warranties, express or implied, including, without limitation, any representations or warranties of merchantability or fitness for a particular purpose. InvestorPoint.com is not an investment adviser. We do not: (a) give investment advice, (b) advocate the purchase or sale of any security or investment and (c) provide, endorse or review any information or data contained herein. We do not guarantee the accuracy of the information and data supplied by information providers. We are not liable or responsible for the quality, accuracy or reliability of this information. You should always seek the assistance of a professional for investment advice.